XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 20,709 $ 9,089 $ 36,435 $ 17,122
General and administrative 8,094 6,013 16,518 11,473
Total operating expenses 28,803 15,102 52,953 28,595
Loss from operations (28,803) (15,102) (52,953) (28,595)
Other income (expense):        
Interest and investment income 4,647 2,556 8,888 4,877
Other expense, net (16) (20) (35) (36)
Total other income, net 4,631 2,536 8,853 4,841
Net loss $ (24,172) $ (12,566) $ (44,100) $ (23,754)
Net loss per share attributable to common shareholders - basic $ (0.43) $ (0.45) $ (0.81) $ (0.85)
Net loss per share attributable to common shareholders - diluted $ (0.43) $ (0.45) $ (0.81) $ (0.85)
Weighted-average common shares outstanding used in net loss per share - basic 56,485,962 28,022,306 54,390,364 27,983,597
Weighted-average common shares outstanding used in net loss per share - diluted 56,485,962 28,022,306 54,390,364 27,983,597